Stay updated on ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Sign up to get notified when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.

Latest updates to the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page
- Check5 days agoChange DetectedRevision updated to v3.4.3. The previous v3.4.2 entry is now obsolete.SummaryDifference0.0%

- Check13 days agoChange DetectedThe new version updates the Study Status and Contacts/Locations sections, reflecting the current trial status and site details.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedVersion 86 adds a new 'Study Status' section to the history and removes the prior funding-status notice.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding status and NIH Clinical Center operations; updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check48 days agoChange DetectedUI updates on the Record History page introduce a glossary toggle, color-coded change indicators (green for additions and red for deletions), and a new site revision note showing v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedRevision v3.3.4 was added to the record history and Revision v3.3.3 was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.